Across TCGA pan-cancer cohorts, ATP6V1G1P3 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of ATP6V1G1P3’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where ATP6V1G1P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ATP6V1G1P3 is over-expressed in tumor.

BRCA, PRAD, and HNSC are the cancer types where ATP6V1G1P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ATP6V1G1P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	+0.102	<.001	6	view →
PRAD	All	All	+0.055	.023	2	view →
HNSC	Male	All	+0.068	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: ATP6V1G1P3 RNA expression & survival · all ATP6V1G1P3 data types